Doris Quon, MD, PhD
Doris V. Quon, MD, PhD, is currently the Medical Director of the Orthopaedic Hemophilia Treatment Center at the Orthopaedic Institute for Children in Los Angeles, California where her focus is on the care of adult patients with hemophilia and other bleeding disorders and their comorbidities. Dr. Quon obtained her Ph.D. as well as her M.D. at the David Geffen School of Medicine at University of California, Los Angeles. She completed her residency in Internal Medicine and Fellowship in Hematology-Oncology at UCLA Medical Center. She is board certified in Internal Medicine and Hematology.
Dr. Quon is medical advisor to the Hemophilia Foundation of Southern California, the local National Hemophilia Foundation Chapter. She is a member of several professional societies, including the International Society on Thrombosis and Haemostasis, the American Society of Hematology, the National Hemophilia Foundation, and the Hemostasis and Thrombosis Research Society. Dr. Quon has authored or co-authored numerous peer-reviewed articles and has been the Principal Investigator of clinical trial studies involving hemophilia therapies including gene therapy.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:BayerDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:BiomarinDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:SanofiDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:NovoNordiskDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Roche/GenentechDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:OctapharmaDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:uniQureDate added:11/28/2021Date updated:11/27/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:TakedaDate added:11/28/2021Date updated:11/27/2023